Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ.
Key claim: Aging-related decline in the mitochondrial membrane lipid cardiolipin causally drives skeletal-muscle fiber-type shifts via ERRγ mitochondria-to-nucleus signaling, and restoring Crls1 reestablishes cardiolipin, reverses atrophy, and rescues premature mortality in mice.
Abstract
Aging paradoxically leads to both a decline in skeletal muscle mitochondrial function and a shift in muscle composition that favors fibers rich in mitochondria. Yet the biological rationale and mechanism underlying this phenomenon remain largely unknown. Here we show that synthesis of the mitochondrial membrane lipid, cardiolipin, causally links mitochondrial dysfunction to fiber-type adaptations in aging mouse and human skeletal muscle. By mimicking the aging decline of skeletal muscle cardiolipin levels in young mice using inducible tissue-specific cardiolipin synthase 1 (Crls1) deletion, we could reproduce key aging hallmarks, including the shift from glycolytic to oxidative fibers. This shift is mediated by mitochondria-to-nucleus signaling through the nuclear receptor, estrogen-related receptor γ, which promotes reactive oxygen species-sensitive glucose uptake and enhanced glycolytic rerouting to sustain antioxidant defenses. Restoring Crls1 expression in adult Crls1 knockout mice reestablishes cardiolipin levels, initiates reversal of muscle atrophy and fully rescues premature mortality. These findings reveal how changes in a mitochondrial membrane lipid cell autonomously orchestrate fiber-type adaptations in aging and myopathies.
Why this matters
Cardiolipin is a mitochondrial inner-membrane phospholipid, not a classical bioenergetic enzyme — identifying its age-related loss as a causal upstream driver of muscle fiber-type shifts and atrophy, acting through ERRγ retrograde signaling, moves the mitochondrial-aging picture from OXPHOS/quality-control toward membrane-lipid composition. The rescue of premature mortality by Crls1 restoration in mice is a strong preclinical causal claim, but the human translation remains correlative (muscle cardiolipin/CRLS1 decline with age) with no interventional readout.